129 related articles for article (PubMed ID: 8256767)
1. A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
Feun LG; Blessing JA; Barrett RJ; Hanjani P
Am J Clin Oncol; 1993 Dec; 16(6):506-8. PubMed ID: 8256767
[TBL] [Abstract][Full Text] [Related]
2. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix: a Gynecological Oncology Group study.
Lincoln S; Blessing JA; McGehee R; Lentz SS
Am J Clin Oncol; 1997 Feb; 20(1):84-5. PubMed ID: 9020296
[TBL] [Abstract][Full Text] [Related]
4. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG).
Muss HB; Blessing JA; Eddy GL; McGehee R
Invest New Drugs; 1992 Apr; 10(1):25-6. PubMed ID: 1607251
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
6. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Rose PG; Blessing JA; Arseneau J
Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
[TBL] [Abstract][Full Text] [Related]
7. A phase II trial of didemnin B (NSC #335319) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
Malfetano JH; Blessing JA; Homesley HD; Look KY; McGehee R
Am J Clin Oncol; 1996 Apr; 19(2):184-6. PubMed ID: 8610646
[TBL] [Abstract][Full Text] [Related]
8. A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: a Gynecologic Oncology Group study.
Jacobs AJ; Blessing JA; Munoz A
Gynecol Oncol; 1992 Mar; 44(3):268-70. PubMed ID: 1541440
[TBL] [Abstract][Full Text] [Related]
9. Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Blessing JA; Malfetano J
Am J Clin Oncol; 1990 Jun; 13(3):191-3. PubMed ID: 2346124
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix.
Irvin WP; Price FV; Bailey H; Gelder M; Rosenbluth R; Durivage HJ; Potkul RK
Cancer; 1998 Jan; 82(2):328-33. PubMed ID: 9445190
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Garcia AA; Blessing JA; Vaccarello L; Roman LD;
Am J Clin Oncol; 2007 Aug; 30(4):428-31. PubMed ID: 17762444
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
13. A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study.
Weiss GR; Green S; Hannigan EV; Boutselis JG; Surwit EA; Wallace DL; Alberts DS
Gynecol Oncol; 1990 Dec; 39(3):332-6. PubMed ID: 2258080
[TBL] [Abstract][Full Text] [Related]
14. A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix--a Gynecologic Oncology Group Study.
Plaxe SC; Blessing JA; Lucci JA; Hurteau JA
Invest New Drugs; 2001; 19(1):77-80. PubMed ID: 11291835
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Malfetano JH; Blessing JA; Homesley HD; Hanjani P
Invest New Drugs; 1991 Feb; 9(1):109-11. PubMed ID: 2026479
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix.
Morris M; Brader KR; Levenback C; Burke TW; Atkinson EN; Scott WR; Gershenson DM
J Clin Oncol; 1998 Mar; 16(3):1094-8. PubMed ID: 9508195
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of isotretinoin and alpha interferon in patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Blessing JA; Nelson BE; Johnson GA; Fowler WC; Reid GC
Am J Clin Oncol; 1998 Dec; 21(6):591-4. PubMed ID: 9856661
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of edatrexate in previously treated squamous cell cervical cancer: a Gynecologic Oncology Group study.
Broun ER; Iseminger KA; Rose PG; Lentz SL; Malfetano JH; Lincoln S; Mannel R
Am J Clin Oncol; 1997 Feb; 20(1):78-80. PubMed ID: 9020294
[TBL] [Abstract][Full Text] [Related]
19. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study.
Look KY; Blessing JA; Levenback C; Kohler M; Chafe W; Roman LD
Gynecol Oncol; 1998 Sep; 70(3):334-8. PubMed ID: 9790784
[TBL] [Abstract][Full Text] [Related]
20. Echinomycin (NSC 526417) in recurrent and metastatic nonsquamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Blessing JA; Hanjani P; Malfetano JH; Kemp GM; Webster K
Am J Clin Oncol; 1992 Aug; 15(4):363-4. PubMed ID: 1325110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]